Suppr超能文献

HLA-DR基因与溃疡性结肠炎难治性之间的独特关系。

Distinct relationship between HLA-DR genes and intractability of ulcerative colitis.

作者信息

Masuda H, Nakamura Y, Tanaka T, Hayakawa S

机构信息

Nihon University School of Medicine, Tokyo, Japan.

出版信息

Am J Gastroenterol. 1994 Nov;89(11):1957-62.

PMID:7942717
Abstract

OBJECTIVE

To explain the correlation between HLA class II genes and the intractability of ulcerative colitis (UC), DR genotyping and clinical analysis were performed for patients with UC.

METHODS

HLA-DRB types and HLA-DR2 subtypes of 45 patients with UC in our hospital were determined using molecular genotyping in combination with sequence-specific oligonucleotide hybridization by polymerase chain reactions. The extent of involvement, clinical course, and treatment were studied to evaluate the intractability of UC.

RESULTS

The gene frequency of DRB11502 in 18 patients with total colitis (0.444) was significantly higher than the group with left-sided colitis and proctitis (0.148; p < 0.05). In addition, DRw11 and DR2 increased significantly in the group including 18 cases with total colitis. In the 11 patients with total colectomy there were no cases with DRB11501, whereas 34 patients without operation included 12 genes of DRB11501 (p < 0.05). In addition, DRw11 increased significantly in the group with total colectomy compared to the group without operation (p < 0.05). When comparing between patients with and without intractability (defined based on the Japanese definition), DRB11502 and DRw11 were found more frequently in intractable UC patients (p < 0.01), whereas DRB1*1501 increased significantly in cases without intractability (p < 0.05).

CONCLUSIONS

DRB11502 or DRw11 have a probability of being closely related to the intractability of UC. In addition, patients with UC possessing DRB11501 have a lower probability of their cases leading to intractable UC. Thus, we believe there are unknown genes present that encode the intractability of UC.

摘要

目的

为解释人类白细胞抗原(HLA)Ⅱ类基因与溃疡性结肠炎(UC)难治性之间的相关性,对UC患者进行了DR基因分型及临床分析。

方法

采用聚合酶链反应结合序列特异性寡核苷酸杂交的分子基因分型方法,测定我院45例UC患者的HLA - DRB类型和HLA - DR2亚型。研究病变累及范围、临床病程及治疗情况,以评估UC的难治性。

结果

18例全结肠炎患者中DRB11502的基因频率(0.444)显著高于左侧结肠炎和直肠炎组(0.148;p<0.05)。此外,在18例全结肠炎患者组中DRw11和DR2显著增加。11例行全结肠切除术的患者中无DRB11501基因,而34例未手术患者中有12例携带DRB11501基因(p<0.05)。此外,与未手术组相比,全结肠切除术组中DRw11显著增加(p<0.05)。在比较难治性患者(根据日本定义)和非难治性患者时,发现难治性UC患者中DRB11502和DRw11出现频率更高(p<0.01),而DRB1*1501在非难治性病例中显著增加(p<0.05)。

结论

DRB11502或DRw11可能与UC的难治性密切相关。此外,携带DRB11501的UC患者发展为难治性UC的可能性较低。因此,我们认为存在未知基因编码UC的难治性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验